trial

Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels

NCTId NCT02652832
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 165 (actual)
Sponsored by Hôpital le Vinatier
Primary completion 2017-10-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
165 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2010-12
Primary completion
2017-10-11
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
non invasive brain stimulation

Sponsors

Hôpital le VinatierLead Sponsor

Investigators

1
jerome brunelin, PhDStudy Director

Sites

1 total
Bron, France

Facts & assertions

4 sourced
Enrollment
165
Phase
NA
Primary Completion Date
2017-10-11
Status
TERMINATED
relationships
The graph out of here
drug
non invasive brain stimulation
drug
lead_sponsor
Hôpital le Vinatier
company
indication
Schizophrenia
indication
Depression
indication
Schizophrenia
indication
investigator
jerome brunelin, PhD
person